# ClinicalTrials.gov record NCT02457156

> PeptideScanner retained ClinicalTrials.gov record NCT02457156 at 2026-07-30T18:30:10.981Z. Its registry update date was 2025-03-13, and PeptideScanner's reviewed identity mapping was octreotide.

- Evidence object: `story:clinicaltrials-gov-nct02457156-octreotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-03-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02457156-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02457156-octreotide-v1.json
- Content SHA-256: `9cb22a85718238248f662ecea33bbac621a06d4e1f1adc60c32a60802adfecfc`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02457156 ([`ctg-observation-nct02457156-2025-03-13-8ac2688d9095`](#source-ctg-observation-nct02457156-2025-03-13-8ac2688d9095))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02457156 at 2026-07-30T18:30:10.981Z. Its registry update date was 2025-03-13, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct02457156-2025-03-13-8ac2688d9095`](#source-ctg-observation-nct02457156-2025-03-13-8ac2688d9095))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02457156 at 2026-07-30T18:30:10.981Z. Its registry update date was 2025-03-13, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct02457156-2025-03-13-8ac2688d9095`](#source-ctg-observation-nct02457156-2025-03-13-8ac2688d9095))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02457156-2025-03-13-8ac2688d9095`](#source-ctg-observation-nct02457156-2025-03-13-8ac2688d9095))

## Sources

<a id="source-ctg-observation-nct02457156-2025-03-13-8ac2688d9095"></a>
- **ClinicalTrials.gov record NCT02457156 · retained source version 2025-03-13:8ac2688d90951970a9e146dc02264411517a8704366dcb9ff44bac767704981b** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02457156) (`ctg-observation-nct02457156-2025-03-13-8ac2688d9095`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02457156." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02457156-octreotide-v1.json SHA-256: 9cb22a85718238248f662ecea33bbac621a06d4e1f1adc60c32a60802adfecfc.